آخر تحديث :
28/05/2025

البحث البحث

دراسة Cyclophosphamide حقنالمضادة للسرطان المخدرات Cyclophosphamide (بريطانيا العظمي, الولايات المتحدة, العربية السعودية, زيلاندا الجديدة)
ATC : L01AA01
دراسة Cyclophosphamide عن طريق الفم  المضادة للسرطان المخدرات ATC : L01AA01
دراسة Cyclophosphamide كبسولةالمضادة للسرطان المخدرات ATC : L01AA01
مراجع 40 Pharm Sci Communications Stability and compatibility studies of four cytostatic agents (fluorouracil, dacarbazine, cyclophosphamide and ifosfamide) with PVC infusion bags.
مراجع 50 Am J Health-Syst Pharm Stability of ondansetron hydrochloride and cyclophosphamide in injectable solutions.
مراجع 170 Am J Hosp Pharm Effect of briefly heating cyclophosphamide solutions.
مراجع 172 J Parenter Sci Technol Chemical stability of two sterile, parenteral formulations of cyclophosphamide (Endoxan) after reconstitution and dilution in commonly used infusion fluids.
مراجع 1728 Pharmazie Stability of cyclophosphamide containing infusions.
مراجع 1833 Ann Pharmacotherapy Stability of cyclophosphamide and mesna admixtures in polyethylene infusion bags.
مراجع 2000 J Pharm Biomed Anal Quality control and stability study using HPTLC: applications to cyclophosphamide in various pharmaceutical products.
مراجع 2016 Am J Health-Syst Pharm Compatibility of palonosetron with cyclophosphamide and with ifosfamide during Y-site administration.
مراجع 3096 Ann Pharmacotherapy Stability of Cyclophosphamide in Extemporaneous Oral Suspensions.
مراجع 4865 Dr REDDY laboratoire Cyclophosphamide REDDY PHARMA 2000 mg/4 ML, solution à diluer pour solution injectable/perfusion. - Résumé des caractéristiques du produit.

  Mentions Légales